|
Patients in the intramuscular group by their basal INR |
|||
| Basal INR < 2,5 (n = 55) |
Basal INR ≥ 2,5 (n = 37) |
95% confidence interval of the difference |
|
|
|
|||
| Mean change circumference of the arm (SD), cm, 24 h |
+0,32 (1,01) |
+0,22 (0,75) |
-0,26 to +0,47 * |
| Patients with increase of the circumference of the arm >= 1 cm, n (%), 24 h |
11 (20,0%) |
7 (18,9%) |
-15,4% to +17,5% |
| Patients with skin lesions in the administration area, n (%), 24 h |
9 (16,4%) |
7 (18,9%) |
-18,5% to +13,4% |
| Mean Visual Analog Pain Scale (SD), 24 h |
0,30 (0,93) |
0,28 (0,70) |
-0,32 to +0,36 * |
| Patients with Visual Analog Pain Scale > 0, n (%), 24 h |
7 (12,7%) |
6 (16,2%) |
-18,3% to +11,3% |
| Mean change INR (SD), 24 h |
-0,02 (0,44) |
-0,13 (0,68) |
-0,14 to +0,37 * |
| Mean change INR (SD), 10d |
+0,14 (0,87) |
-0,03 (1,01) |
-0,23 to +0,58 * |
|
*Calculated under the checked assumption of variance homogeneity of both samples. | |||
Casajuana et al. BMC Blood Disorders 2008 8:1 doi:10.1186/1471-2326-8-1 |
|||